Short Interest Alert: After Reaching Milestone, Is Advisory Board Company The (NASDAQ:ABCO)’s Short Interest Revealing Something?

November 23, 2016 - By Darrin Black   ·   0 Comments

Short Interest Alert: After Reaching Milestone, Is Advisory Board Company The (NASDAQ:ABCO)’s Short Interest Revealing Something?

The stock of Advisory Board Company The (NASDAQ:ABCO) registered a decrease of 1.84% in short interest. ABCO’s total short interest was 1.57 million shares in November as published by FINRA. Its down 1.84% from 1.60 million shares, reported previously. With 185,900 shares average volume, it will take short sellers 9 days to cover their ABCO’s short positions. The short interest to Advisory Board Company The’s float is 4.19%. The stock decreased 0.14% or $0.05 during the last trading session, hitting $36.95. The Advisory Board Company (NASDAQ:ABCO) has risen 17.34% since April 21, 2016 and is uptrending. It has outperformed by 12.01% the S&P500.

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The company has a market cap of $1.53 billion. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value care and population health, revenue cycle, clinical activities and supply chain. It currently has negative earnings. The Company’s higher education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations.

Insitutional Activity: The institutional sentiment increased to 1.26 in Q2 2016. Its up 0.32, from 0.94 in 2016Q1. The ratio is positive, as 25 funds sold all The Advisory Board Company shares owned while 53 reduced positions. 28 funds bought stakes while 45 increased positions. They now own 39.77 million shares or 7.82% less from 43.15 million shares in 2016Q1.
Barclays Public Ltd Co holds 0% of its portfolio in The Advisory Board Company (NASDAQ:ABCO) for 57 shares. Menta Cap Limited holds 0.12% of its portfolio in The Advisory Board Company (NASDAQ:ABCO) for 23,700 shares. Citadel Advisors Ltd holds 0% or 12,635 shares in its portfolio. State Board Of Administration Of Florida Retirement Sys last reported 31,823 shares in the company. Pacad Investment, a British Columbia – Canada-based fund reported 4,000 shares. The New York-based Alliancebernstein Limited Partnership has invested 0% in The Advisory Board Company (NASDAQ:ABCO). Raymond James And Assoc last reported 7,067 shares in the company. Bernzott Cap Advsr last reported 531,565 shares in the company. Federated Pa last reported 0% of its portfolio in the stock. Ladenburg Thalmann Financial Serv accumulated 0% or 75 shares. Thrivent Fincl For Lutherans last reported 41,720 shares in the company. Walleye Trading Ltd Co reported 2,470 shares or 0% of all its holdings. California Pub Employees Retirement holds 52,200 shares or 0% of its portfolio. Moreover, Rivulet Capital Ltd Liability Corporation has 4.92% invested in The Advisory Board Company (NASDAQ:ABCO) for 515,000 shares. The Massachusetts-based Granahan Invest Inc Ma has invested 0.7% in The Advisory Board Company (NASDAQ:ABCO).

Insider Transactions: Since May 31, 2016, the stock had 1 buy, and 14 sales for $1.36 million net activity. 2,924 shares with value of $119,738 were sold by Farber Evan R on Wednesday, August 17. Miller Cormac F had sold 1,500 shares worth $64,560. Another trade for 5,000 shares valued at $164,050 was bought by KINDICK KELT. ZUMWALT LEANNE M had sold 2,736 shares worth $114,091 on Monday, August 1. On Monday, November 14 the insider Musslewhite Robert W sold $180,840. 2,400 shares were sold by Kirshbaum Michael T, worth $102,720 on Thursday, October 20. Shares for $103,600 were sold by GRUA PETER J.

The Advisory Board Company (NASDAQ:ABCO) Ratings Coverage

Out of 14 analysts covering Advisory Board (NASDAQ:ABCO), 9 rate it a “Buy”, 1 “Sell”, while 4 “Hold”. This means 64% are positive. $65 is the highest target while $40 is the lowest. The $53.60 average target is 45.06% above today’s ($36.95) stock price. Advisory Board has been the topic of 19 analyst reports since August 5, 2015 according to StockzIntelligence Inc. Robert W. Baird upgraded the stock to “Outperform” rating in Monday, August 17 report. The company was maintained on Wednesday, August 5 by Canaccord Genuity. As per Wednesday, November 2, the company rating was maintained by Stifel Nicolaus. As per Wednesday, August 5, the company rating was maintained by Oppenheimer. The company was upgraded on Monday, August 31 by BMO Capital Markets. Deutsche Bank upgraded The Advisory Board Company (NASDAQ:ABCO) rating on Thursday, February 25. Deutsche Bank has “Buy” rating and $43 price target. The stock has “Sector Weight” rating given by KeyBanc Capital Markets on Monday, April 18. The firm earned “Overweight” rating on Friday, September 30 by Barclays Capital. The stock has “Overweight” rating given by JP Morgan on Tuesday, November 17. The rating was downgraded by Zacks to “Strong-Buy” on Friday, August 7.

ABCO Company Profile

The Advisory Board Company, incorporated on August 9, 2001, is a well-known provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value care and population health, revenue cycle performance, clinical activities and supply chain management. The Company’s education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations. The Firm offers distinct membership programs, across four areas, which include best practices research and insight, performance technology software, consulting and management services, and data- and tech-enabled services.

More important recent The Advisory Board Company (NASDAQ:ABCO) news were published by: Prnewswire.com which released: “The Advisory Board Company to Participate in the Piper Jaffray Healthcare …” on November 22, 2016, also Prnewswire.com published article titled: “The Advisory Board Company Reports Third Quarter Results”, Globenewswire.com published: “The Advisory Board Company (Nasdaq: ABCO) to Ring The Nasdaq Stock Market …” on November 17, 2016. More interesting news about The Advisory Board Company (NASDAQ:ABCO) was released by: Prnewswire.com and their article: “The Advisory Board Company to Report Third Quarter Financial Results After …” with publication date: October 11, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Darrin Black


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>